🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/06/2008 | 10,03 | 10,03 | 9,62 | 9,77 | -3,69% | 4,10% | 69.837 |
| 25/06/2008 | 9,54 | 10,22 | 9,39 | 10,14 | +6,27% | 8,63% | 92.520 |
| 24/06/2008 | 9,81 | 9,92 | 9,25 | 9,54 | -3,77% | 6,87% | 137.805 |
| 23/06/2008 | 10,22 | 10,56 | 9,73 | 9,92 | -6,36% | 8,06% | 185.681 |
| 20/06/2008 | 9,96 | 10,59 | 9,43 | 10,59 | +5,60% | 11,65% | 232.836 |
| 19/06/2008 | 9,96 | 10,14 | 9,62 | 10,03 | +0,37% | 5,26% | 115.523 |
| 18/06/2008 | 10,29 | 10,44 | 9,84 | 9,99 | -4,30% | 5,82% | 138.259 |
| 17/06/2008 | 10,74 | 10,82 | 10,22 | 10,44 | -2,79% | 5,58% | 82.047 |
| 16/06/2008 | 10,74 | 11,23 | 10,63 | 10,74 | -0,35% | 5,57% | 84.024 |
| 13/06/2008 | 10,63 | 11,04 | 10,52 | 10,78 | +2,86% | 4,93% | 38.392 |
| 12/06/2008 | 10,52 | 11,23 | 10,33 | 10,48 | +0,72% | 8,54% | 98.050 |
| 11/06/2008 | 11,27 | 11,64 | 10,41 | 10,41 | -7,95% | 10,96% | 120.465 |
| 10/06/2008 | 11,64 | 11,64 | 11,04 | 11,30 | -3,82% | 5,14% | 76.917 |
| 09/06/2008 | 12,24 | 12,35 | 11,27 | 11,75 | -4,27% | 8,87% | 99.172 |
| 06/06/2008 | 13,06 | 13,06 | 12,16 | 12,28 | -6,82% | 6,88% | 105.985 |
| 05/06/2008 | 12,61 | 13,18 | 12,35 | 13,18 | +4,45% | 6,53% | 138.152 |
| 04/06/2008 | 12,61 | 13,18 | 12,28 | 12,61 | -1,46% | 7,12% | 81.165 |
| 03/06/2008 | 12,43 | 13,44 | 12,24 | 12,80 | +3,32% | 9,64% | 193.883 |
| 02/06/2008 | 13,14 | 13,55 | 11,79 | 12,39 | -5,70% | 13,39% | 421.055 |
| 30/05/2008 | 8,83 | 14,45 | 8,68 | 13,14 | +49,36% | 65,25% | 2.106.182 |
| 29/05/2008 | 8,61 | 9,47 | 8,08 | 8,80 | +2,17% | 16,09% | 696.691 |
| 28/05/2008 | 11,42 | 11,45 | 8,08 | 8,61 | -35,93% | 29,51% | 1.050.847 |
| 27/05/2008 | 12,99 | 13,47 | 12,99 | 13,44 | +4,36% | 3,75% | 54.101 |
| 23/05/2008 | 13,03 | 13,18 | 12,76 | 12,88 | -1,99% | 3,16% | 39.674 |
| 22/05/2008 | 13,18 | 13,44 | 13,03 | 13,14 | +0,00% | 3,12% | 55.838 |
| 21/05/2008 | 13,81 | 14,07 | 13,10 | 13,14 | -4,36% | 7,05% | 84.745 |
| 20/05/2008 | 13,74 | 13,81 | 13,18 | 13,74 | -0,54% | 4,63% | 84.398 |
| 19/05/2008 | 14,04 | 14,11 | 13,47 | 13,81 | -0,81% | 4,53% | 102.165 |
| 16/05/2008 | 13,36 | 14,04 | 13,10 | 13,92 | +5,98% | 7,00% | 135.747 |
| 15/05/2008 | 13,70 | 13,85 | 13,10 | 13,14 | -4,36% | 5,46% | 79.936 |